Table 3: Substance use and perceptions and sexual activity among FTO CINI sexual minority and non-sexual minority adolescents.
| Total sample (n=423) |
Sexual minorities (n=133) |
Non-sexual minorities (n=290) |
|||
|---|---|---|---|---|---|
| X2 | p | ||||
| Self-endorsed substance use, n (%) | |||||
| Alcohol | 138 (32.9) | 62 (46.6) | 76 (26.6) | 16.51 | <.001 |
| Cannabis | 204 (49.3) | 79 (59.9) | 125 (44.3) | 8.66 | .009 |
| Other drugs a | 55 (13.4) | 26 (20.2) | 29 (10.3) | 7.44 | .014 |
| Any drug or alcohol | 222 (52.7) | 89 (66.9) | 133 (46.2) | 15.69 | <.001 |
| Had sexual intercourse, lifetime (%) b | 166 (40.2) | 61 (45.9) | 105 (37.5) | 2.62 | .191 |
| Had sexual intercourse, past 4 months (%) b | 124 (29.9) | 45 (33.8) | 79 (28.0) | 1.46 | .251 |
| Adolescent or partner was intoxicated during sex, past 4 months (%) c | 61 (50.4) | 30 (68.2) | 31 (40.3) | 8.73 | .009 |
| t(df) | p | ||||
| Consequences of substance use, total score (SD) d | |||||
| B-YAACQ | 2.6 (3.4) | 3.0 (3.8) | 2.2 (3.0) | −1.33 (136) | .264 |
| B-MACQ | 2.6 (3.2) | 3.0 (3.7) | 2.3 (2.7) | −1.52 (199) | .216 |
| Peer tolerance of substance use, mean score (SD) | |||||
| Alcohol use | .7(1.2) | 1.0 (1.4) | .7(1.1) | −2.89 (399) | .010 |
| Cannabis use | 1.6 (1.8) | 2.0 (1.9) | 1.4 (1.7) | −3.15 (404) | .006 |
| Other drug use e | .5 (1.1) | .7 (1.3) | .4 (1.0) | −2.16 (399) | .066 |
| Any drug or alcohol use | .9 (1.1) | 1.2 (1.3) | .8 (1.0) | −3.09 (406) | .007 |
| z | p | ||||
| Median number of sexual partners, lifetime (IQR) b | 0 (0-2) | 0 (0-2) | 0 (0-1) | −1.89 | .112 |
| Median number of sexual partners, past 4 months (IQR) b | 0 (0-1) | 0 (0-1) | 0 (0-1) | −1.53 | .219 |
Abbreviations: B-MACQ, Brief Marijuana Consequences Questionnaire; B-YAACQ, Brief Young Adult Alcohol Consequences Questionnaire
Bolded values indicate significant differences between sexual-minority and non-sexual-minorities, P<05. The Benjamini-Hochberg procedure was applied to control the false-discovery rate at 5%. All variables in this table were derived from adolescent self-report.
Includes synthetic cannabis, inhalants, synthetics (e.g., bath salts), methamphetamines, cocaine, injection drugs (e.g., cocaine, heroin), club or psychedelic drugs, tranquilizers/benzodiazepines, misuse of prescription drugs, and misuse of other drugs (e.g., steroids).
Defined as oral, vaginal, or anal sex
Among adolescents who endorsed having sex within the past 4 months
Within the past 4 months, excludes adolescents who denied use of alcohol (B-YAACQ) or cannabis (B-MACQ)
Defined as “other drugs besides marijuana”